PerfuseCell Cronus A/S: Financial statements 2020
CVR: 31606810
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
PerfuseCell Cronus A/S (CVR 31606810) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 385,093 and a net result of DKK 86,806 compared with DKK 172,271 the year before. That is an increase of 75% compared with the year before. The profit margin was 22.5%. Equity in the 2020 report amounted to DKK 749,667. The solvency ratio was 100%.
- Revenue
- DKK 385,093
- Gross Profit
- DKK 86,806
- Profit/Loss
- DKK 86,806
- Equity
- DKK 749,667
- Total Assets
- DKK 749,667
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 385 t. | 87 t. | 87 t. | 750 t. | - |
| 2019 | 220 t. | 172 t. | 172 t. | 663 t. | - |
| 2018 | 532 t. | 272 t. | 168 t. | 491 t. | - |
| 2017 | 1.7 mio. | 310 t. | 309 t. | 323 t. | - |
| 2016 | 0 | 0 | 0 | 14 t. | - |
Official annual report
How creditworthy is PerfuseCell Cronus A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
PerfuseCell Cronus A/S has published its annual report for 2019. Revenue came to DKK 220,101, and the net result was DKK 172,271.
About PerfuseCell Cronus A/S
PerfuseCell Cronus A/S is a Danish company of the type Aktieselskab based in Herlev, founded in 2008. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named PerfuseCell A/S and PumpCell A/S. The management consists of Per Stobbe. The board consists of August Kisling Stobbe, Flemming Petersen and Per Stobbe. The company is owned by Stobbe GmbH. In 2025, the company reported a gross profit of DKK 20,467 and a net result of DKK 23,973 compared with DKK 2,216 the year before. Equity in the 2025 report amounted to DKK 1,070,836.